FDA Warns Chinese API Manufacturer Over Quality Management, Record-Keeping

The FDA warned Chinese API manufacturer Changzhou Jintan Qianyao Pharmaceutical Raw Materials for inadequate quality management and record-keeping.
Source: Drug Industry Daily